Investing.com-- Pfizer heads into its second-quarter report on Tuesday with investors' attention split between the routine churn of a maturing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE